1. Ramírez E, Rossignoli T, Campos AJ, Muñoz R, Zegarra C, Tong H,
Medrano N, Borobia AM, Carcas AJ, Frías J. Drug-induced life-threatening
potassium disturbances detected by a pharmacovigilance program from
laboratory signals. Eur J Clin Pharmacol. 2013 Jan;69(1):97-110. doi:
10.1007/s00228-012-1303-9. Epub 2012 May 31. PMID: 22648277.
2. Velázquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of
trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug
15;119(4):296-301. doi: 10.7326/0003-4819-119-4-199308150-00008. PMID:
8328738.
3. Al AdAwi RM, Albu-Mahmood Z, Abdelgelil M, Abdelaziz H, Stewart D,
Awaisu A. Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary
Care Hospital. Risk Manag Healthc Policy. 2021;14:519-525.
Published 2021 Feb 11. doi:10.2147/RMHP.S283471
4. Nickels LC, Jones C, Stead LG. Trimethoprim-sulfamethoxazole-induced
hyperkalemia in a patient with normal renal function. Case Rep Emerg
Med. 2012;2012:815907. doi: 10.1155/2012/815907. Epub 2012 Dec 13. PMID:
23326725; PMCID: PMC3542892.
5. Koç M, Bihorac A, Ozener CI, Kantarci G, Akoglu E. Severe
hyperkalemia in two renal transplant recipients treated with standard
dose of trimethoprim-sulfamethoxazole. Am J Kidney Dis. 2000
Sep;36(3):E18. doi: 10.1053/ajkd.2000.16220. PMID: 10977811.
6. More AS, Bhange NR, Gadekar KG, Kulkarni SG. Trimethoprim-induced
hyperkalemia in renal transplant recipient. Indian J Transplant
2018;12:149-51.
7. Alappan R, Buller GK, Perazella MA. Trimethoprim-sulfamethoxazole
therapy in outpatients: is hyperkalemia a significant problem? Am J
Nephrol. 1999;19(3):389-94. doi: 10.1159/000013483. PMID: 10393376.